# Implantation or Injectable Dosage Form New Animal Drugs; Enrofloxacin Solution
> **Food and Drug Administration** · Final rule. · Published 1997-07-21 · 62 FR 38907
## Document
- **Document number:** 97-19126
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 62 FR 38907
- **CFR reference:** 21 CFR 522
- **Publication date:** 1997-07-21
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Bayer Corp., Agriculture Div., Animal Health. The supplemental NADA provides for revised indications for use of enrofloxacin injectable solution in dogs for the management of diseases associated with bacteria susceptible to enrofloxacin.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/1997/07/21/97-19126/implantation-or-injectable-dosage-form-new-animal-drugs-enrofloxacin-solution)
---
*AI Analytics · CC0 1.0*